First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial
Enrollment remains on track with internal interim results expected in Q2 2026Randomized study to evaluate Nociscan’s ability to improve surgical...
Clinical Trial
Scilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in Bitcoin
PALO ALTO, Calif., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative...
Levicept to Present Key New Data from Phase II Trial of LEVI-04, a Novel Neurotrophin-3 Inhibitor, at ACR Convergence 2025
A significant, dose-dependent reduction in bone marrow lesion presence and area was observed for LEVI-04 compared with placebo in patients...
Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292
This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR")....
VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001
image1 VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001 Japanese regulator, the PMDA, waived the...
Unbuzzd Wellness Raising Up To $5 Million USD Through Reg D 506 (c) Offering; Hosting Live Webinar and Q&A for Interested Accredited Investors on Wednesday, October 1, 2025 at 4:30 PM EST (1:30 PM PST)
Vancouver, British Columbia--(Newsfile Corp. - September 25, 2025) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzdTM...
Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made...
Suvoda and Greenphire complete brand integration with unified website and social media presence
CONSHOHOCKEN, Pa., Sept. 24, 2025 /PRNewswire/ -- Suvoda LLC, a global clinical trial technology company, today announced the completion of...
Cognision and SOMNOmedics Forge Strategic Partnership to Advance Sleep Biomarkers in Pharmaceutical Clinical Trials
LOUISVILLE, Ky., Sept. 24, 2025 /PRNewswire/ -- Cognision, a leader in high-performance neurophysiological biomarker solutions and services, has announced a...
Digital Migraine Treatment Devices Market to Reach USD 298.71 Million by 2030, Fueled by Non-Invasive Neuromodulation and Expanding Clinical Adoption | DataM Intelligence
AUSTIN, Texas and TOKYO, Sept. 24, 2025 /PRNewswire/ --The Digital Migraine Treatment Devices Market is witnessing rapid adoption as patients...
Nira Medical and Rocky Mountain MS Clinic to Present First of Its Kind AI-Powered Multiple Sclerosis Registry at ECTRIMS 2025
Integrating Century Health's novel large language model (LLM) with electronic health records (EHRs) rapidly delivered 130k+ clinical variables to advance...
Lunit, CellCarta Announce Global Alliance to Expand Access to Digital Pathology AI for Clinical Trials
SEOUL, South Korea and MONTREAL, Sept. 24, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics...
Avant Technologies, Art-Islets, and Austrianova Announce Joint Venture to Advance Diabetes Treatment
LAS VEGAS, Sept. 24, 2025 /PRNewswire/ -- Avant Technologies, Inc. (OTCQB: AVAI) ("Avant" or the "Company"), a Nevada-based corporation, Art-Islets Pte. Ltd....
Tapping LATAM’s Untapped Patient Pool for Ophthalmology Trials, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn why Latin America (LATAM) is becoming a strategic hotspot for ophthalmology clinical trials amid global...
The Breast Cancer Research Foundation Awards Record-Breaking $74.75M in Scientific Grants in Year of Exceptional Turmoil in Scientific Funding
BCRF responds to scientific community's urgent need to sustain research NEW YORK, Sept. 24, 2025 /PRNewswire/ -- At a time...
IgniteData Selected for Microsoft for Startups Pegasus Program: Agentic AI Powers Archer Solution to Transform Clinical Trial Data Transfer
NEW CASTLE, Del., Sept. 24, 2025 /PRNewswire/ -- IgniteData, the healthtech company behind Archer—an advanced EHR-to-EDC solution delivering fully automated, regulatory-grade...
New Data for BRIUMVI® Demonstrate 89.9% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 6 Years of Continuous BRIUMVI Treatment
During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every...
Kyverna Therapeutics Highlights Potential of KYV-101 in Multiple Sclerosis with Data from Phase 1 Investigator-Initiated Trials to be Presented at ECTRIMS
KYV-101 IIT data demonstrate promising clinical activity, including robust CAR T penetration into the central nervous system (CNS) and improved...
Medicus Pharma Ltd. To Present at Brookline Capital Markets
The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell...
Alira Health Becomes First Platinum CRO Partner of the Wound Care Collaborative Community, Expanding Ongoing Work to Advance Wound Healing Innovation
FRAMINGHAM, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Alira Health announced today that it has become the first Platinum CRO...